Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(12)
•••
Post by jopatcloon Oct 09, 2024 12:25pm
84 Views
Post# 36259537

❤ Take Heart Conference the Ollie conference last week 📍🚀

❤ Take Heart Conference the Ollie conference last week 📍🚀Good  DD@hassy I would highly recommend anyone interested to learn what you are investing in by listening to the replay of the Ollie conference last week. https://beacon360.content.online/xbcs/S2571/catalog/resource.xhtml;jsessionid=20202d1340534c8fb116898d18bf?eid=71638 specifically starting about 12 minutes mark, Dr. Soriano comes on, and 2h36 minutes mark, the video from British Heart foundation (same one from earlier this year).Day 1 - Take Heart Conference
  •  Video MPEG-4 , size 562358 KB
And remember 
good news . (Ventripoint selected as a trusted solution for cardiac imaging ; presented at Take Heart conference Ventripoint logo and Ascend Cardiovascular Take Heart conference https://theohhf.org/take-heart-conference/) plus last week's news The BEST automation and analysis on the PLANET GEN3EHO On website Ascend https://ascendcv.com/ It would be perfect to have FDA 4.0 before BSEcho 2024! We currently have eight annual partners: Ventripoint + PHILIPS +GE HealthCare + FUJIFILM and other major healthcare companies...https://www.bsecho.org/Public/Public/About-Us/Partners/Industry-partners.aspx?hkey
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities